![Cureus | "Getting Under Your Skin”: First Reported Case of Transient Reactive Phlebitis Involving Vancomycin Infusion Therapy | Article Cureus | "Getting Under Your Skin”: First Reported Case of Transient Reactive Phlebitis Involving Vancomycin Infusion Therapy | Article](https://assets.cureus.com/uploads/figure/file/250747/article_river_c1fbca90fdc911eb8f4bd1bd51f09aa5-Screen-Shot-2021-08-15-at-2.17.53-AM.png)
Cureus | "Getting Under Your Skin”: First Reported Case of Transient Reactive Phlebitis Involving Vancomycin Infusion Therapy | Article
![Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports](https://casereports.bmj.com/content/casereports/2016/bcr-2016-216448/F3.large.jpg)
Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports
![Management, clinical outcomes, and complications of acute cannula-related peripheral vein phlebitis of the upper extremity: A retrospective study | Semantic Scholar Management, clinical outcomes, and complications of acute cannula-related peripheral vein phlebitis of the upper extremity: A retrospective study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b35796efdabf763fba038f0219a56c8d9066bc0b/5-Figure1-1.png)
Management, clinical outcomes, and complications of acute cannula-related peripheral vein phlebitis of the upper extremity: A retrospective study | Semantic Scholar
![Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports](https://casereports.bmj.com/content/casereports/2016/bcr-2016-216448/F2.large.jpg)
Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports
![Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports](https://casereports.bmj.com/content/casereports/2016/bcr-2016-216448/F1.large.jpg)